Paper Details

  1. Home
  2. Paper Details

Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.

Author: , BonnierH J, BonserR, BullerN, JateneA, MorelM A, SchönbergerJ P, SerruysP W, SousaJ E, UngerF, van HerwerdenL A, van HoutB A, van den BrandM J

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Coronary stenting for multivessel disease is less expensive than bypass surgery and offers the same degree of protection against death, stroke, and myocardial infarction. However, stenting is associated with a greater need for repeated revascularization.
Paper Details　
Original Abstract of the Article :
BACKGROUND: The recent recognition that coronary-artery stenting has improved the short- and long-term outcomes of patients treated with angioplasty has made it necessary to reevaluate the relative benefits of bypass surgery and percutaneous interventions in patients with multivessel disease. METHO...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1056/NEJM200104123441502

データ提供：米国国立医学図書館（NLM）

Coronary Artery Bypass Surgery vs. Stenting: A Choice in the Desert of Cardiovascular Care

Cardiovascular medicine is a vast and complex field, where researchers and clinicians work tirelessly to improve the lives of patients with heart disease. This study explores the relative benefits of coronary artery bypass surgery (CABG) and stenting for the treatment of multivessel disease, a condition affecting multiple coronary arteries. The researchers conducted a randomized controlled trial to compare the long-term outcomes of these two procedures in patients with multivessel disease.

CABG vs. Stenting: Two Paths in the Desert

The study found that CABG and stenting were comparable in terms of preventing death, stroke, or myocardial infarction. However, stenting was associated with a higher rate of repeat revascularization, suggesting that CABG might offer a more durable solution for patients with multivessel disease. Think of CABG and stenting as two different paths through the desert of cardiovascular care. CABG might offer a more stable and long-lasting solution, while stenting may be a more convenient option with a higher risk of needing further intervention. This study provides valuable insights for guiding patient care decisions in the management of multivessel disease.

Balancing Costs and Benefits in Cardiovascular Care

The study also highlights the importance of balancing costs and benefits in cardiovascular care. While stenting was less expensive upfront, the higher rate of repeat revascularization ultimately led to higher overall costs. This underscores the need for a comprehensive assessment of both short-term and long-term costs and benefits when making decisions about coronary revascularization procedures. This research emphasizes the importance of careful consideration of all factors when choosing the best treatment option for patients with multivessel disease.

Dr.Camel's Conclusion

This randomized controlled trial provides valuable insights into the relative benefits and risks of CABG and stenting for multivessel disease. The study underscores the importance of considering both short-term and long-term outcomes when choosing the best treatment option for patients. This research emphasizes the need for a comprehensive approach to patient care, balancing costs, benefits, and individual patient needs in the challenging desert of cardiovascular medicine.

Date :
  1. Date Completed 2001-04-26
  2. Date Revised 2010-11-18
Further Info :

Pubmed ID

11297702

DOI: Digital Object Identifier

10.1056/NEJM200104123441502

Related Literature

Article Analysis
・Effective treatment of angioplasty
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.